The laminins belong to a family of trimeric basement membrane glycoproteins
with multiple domains, structures, and functions. Endothelial cells bind l
aminin-1 and form capillary-like structures when plated on a laminin-1-rich
basement membrane matrix, Matrigel. Laminin-1 is composed of 3 chains, alp
ha 1, beta 1, and gamma 1. Because laminin-1 is known to contain multiple b
iologically active sites, we have screened 156 synthetic overlapping peptid
es spanning the entire laminin gamma 1 chain for potential angiogenic seque
nces. Only 7 of these peptides, designated as C16, C25, C30, C38, C64, C75,
and C102, disrupted the formation of capillary-like structures by human um
bilical vein endothelial cells on Matrigel. Dose-response experiments in th
e presence of 50 to 200 mu g/mL showed that tube formation was prevented by
most peptides at 150 and 200 mu g/mL, except for C16, which showed strong
activity at all concentrations. Active peptides promoted vessel sprouting f
rom aorta rings and angiogenesis in the chick chorioallantoic membrane assa
y. In addition, the active peptides also promoted endothelial cell adhesion
to dishes coated with 0.1 mu g of peptide and inhibited attachment to lami
nin-1 but not to plastic or fibronectin. Four of the active peptides, C25,
C38, C75, and C102, may have cell-type specificity with endothelial cells,
since they did not promote PC12 neurite outgrowth or adhesion of B16-F10 me
lanoma and human submandibular gland cells. These results suggest that spec
ific laminin gamma 1-chain peptides have angiogenic activity with potential
therapeutic applications.